Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check7 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check21 days agoChange DetectedThe site footer now identifies release v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0; the page continues to show a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now displays a 403 Forbidden error, making the NEOMUN study record inaccessible. The content including study documents and related details appears to have been removed from the page.SummaryDifference19%

- Check70 days agoChange DetectedAdded a funding line: '2016 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers and updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.